Stay updated on CAB-AXL-ADC Study in NSCLC Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC Study in NSCLC Clinical Trial page.

Latest updates to the CAB-AXL-ADC Study in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check26 days agoChange DetectedThe web page has been updated to reflect the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.2.SummaryDifference2%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check76 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a clinical study on CAB-AXL-ADC for non-small-cell lung cancer, including detailed study objectives, criteria, and previous version information. The only notable addition is a new revision number.SummaryDifference12%
- Check84 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 13, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.SummaryDifference0.5%
Stay in the know with updates to CAB-AXL-ADC Study in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC Study in NSCLC Clinical Trial page.